Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer

Clinical trial NCT00920192 · COMPLETED

Trial details

NCT number: NCT00920192
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2009-08-12
Primary completion: 2012-03-07
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.